BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18542057)

  • 1. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
    Araki K; Kawauchi K; Tanaka N
    Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
    Hu XT
    Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.
    Kawauchi K; Araki K; Tobiume K; Tanaka N
    Biochem Biophys Res Commun; 2008 Jul; 372(1):137-41. PubMed ID: 18477470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
    Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
    Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
    Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
    Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
    Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
    Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
    Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.
    McCabe MT; Low JA; Imperiale MJ; Day ML
    Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending the nuclear roles of IkappaB kinase subunits.
    Gloire G; Dejardin E; Piette J
    Biochem Pharmacol; 2006 Oct; 72(9):1081-9. PubMed ID: 16846590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
    Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
    J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.